Unknown

Dataset Information

0

A glycolytic metabolite restores DNA repair activity of polynucleotide kinase 3'-phosphatase in polyglutamine (PolyQ) diseases.


ABSTRACT: We previously reported that the loss of activity of an essential DNA repair enzyme, polynucleotide kinase 3'-phosphatase (PNKP), resulted in accumulation of double strand breaks (DSB) in patient's brain genome in Huntington's disease (HD) and Spinocerebellar ataxia type 3 (SCA3). Here we document that PNKP interacts with the nuclear isoform of phosphofructokinase fructose-2,6-bisphosphatase 3 (PFKFB3), which converts fructose-6-phosphate (F6P) into fructose-2,6-bisphosphate (F2,6BP), a potent allosteric modulator of glycolysis. Depletion of PFKFB3 markedly abrogates PNKP activity, thereby affecting PNKP mediated transcription-coupled non-homologous end joining (TC-NHEJ). Both PFKFB3 and F2,6BP levels are significantly lower in the nuclear extracts of HD and SCA3 patients' brains. Exogenous F2,6BP restored PNKP activity in the brain nuclear extracts of those samples. Moreover, delivery of F2,6BP into HD mouse striata-derived neuronal cells restored PNKP activity, transcribed genome integrity and cellular viability. We thus postulate that F2,6BP serves in vivo as a cofactor for proper functionality of PNKP and thereby of brain health. Our results thus provide a compelling rationale for exploring therapeutic use of F2,6BP and related compounds for treating polyQ diseases.

SUBMITTER: Chakraborty A 

PROVIDER: S-EPMC10634858 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease.

Chakraborty Anirban A   Sreenivasmurthy Sravan Gopalkrishnashetty SG   Miller Wyatt W   Huai Weihan W   Biswas Tapan T   Mandal Santi Mohan SM   Boscá Lisardo L   Krishnan Balaji B   Ghosh Gourisankar G   Hazra Tapas T  

bioRxiv : the preprint server for biology 20240716


Huntington's disease (HD) and spinocerebellar ataxia type 3 (SCA3) are the two most prevalent polyglutamine (polyQ) neurodegenerative diseases, caused by CAG (encoding glutamine) repeat expansion in the coding region of the huntingtin (HTT) and ataxin-3 (ATXN3) proteins, respectively. We have earlier reported that the activity, but not the protein level, of an essential DNA repair enzyme, polynucleotide kinase 3'-phosphatase (PNKP), is severely abrogated in both HD and SCA3 resulting in accumula  ...[more]

Similar Datasets

| S-EPMC3333865 | biostudies-literature
| S-EPMC10440501 | biostudies-literature
| S-EPMC5469602 | biostudies-literature
| S-EPMC4601665 | biostudies-literature
| S-EPMC1370887 | biostudies-literature
| S-EPMC5161711 | biostudies-literature
| S-EPMC10954452 | biostudies-literature
| S-EPMC3128972 | biostudies-literature
| S-EPMC10461918 | biostudies-literature
| S-EPMC2761019 | biostudies-literature